Synlogic, Inc. Files 2024 10-K, Cites October 2023 Financing
Ticker: SYBX · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1527599
| Field | Detail |
|---|---|
| Company | Synlogic, Inc. (SYBX) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financing, securities-offering, pharmaceuticals
Related Tickers: SYBX
TL;DR
SYBX 2024 10-K filed. Mentions Oct '23 financing & stock/warrant offerings.
AI Summary
Synlogic, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 6, 2025. The company, formerly known as Mirna Therapeutics, Inc., is involved in the pharmaceutical preparations industry. Key financial events mentioned include an October 2023 financing and an underwritten public offering of common stock and warrants. The filing also references its common stock and warrants, as well as pre-funded warrants.
Why It Matters
This filing provides a comprehensive overview of Synlogic's financial health and operational status for the past fiscal year, crucial for investors assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The filing details financial activities like public offerings and financing, which can indicate periods of growth or financial strain, requiring careful investor scrutiny.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-06 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- SYNLOGIC, INC. (company) — Filer
- Mirna Therapeutics, Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-06 (date) — Filing date
- October 2023 (date) — Financing event
- Common Stock and Warrants (dollar_amount) — Securities offered
- Pre-funded Warrants (dollar_amount) — Securities offered
FAQ
What was the primary business of Synlogic, Inc. during the fiscal year ending December 31, 2024?
Synlogic, Inc. is categorized under Pharmaceutical Preparations (SIC 2834), indicating its primary business involves the development and manufacturing of pharmaceutical products.
When did Synlogic, Inc. change its name from Mirna Therapeutics, Inc.?
The company changed its name from Mirna Therapeutics, Inc. on August 9, 2011.
What significant financing event is mentioned in relation to Synlogic, Inc. in October 2023?
The filing references 'October2023FinancingMember', indicating a financing event occurred in October 2023.
What types of securities were part of the October 2023 financing or related offerings?
The filing mentions 'CommonStockAndWarrantsMember' and 'PreFundedWarrantsMember', suggesting these securities were involved.
Where is Synlogic, Inc. headquartered?
Synlogic, Inc.'s business and mailing address is PO BOX 30, Winchester, MA 01890.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding SYNLOGIC, INC. (SYBX).